A detailed history of Harvest Investment Services, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Harvest Investment Services, LLC holds 3,872 shares of ABBV stock, worth $638,841. This represents 0.26% of its overall portfolio holdings.

Number of Shares
3,872
Previous 5,129 24.51%
Holding current value
$638,841
Previous $879,000 13.08%
% of portfolio
0.26%
Previous 0.36%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $205,946 - $250,557
-1,257 Reduced 24.51%
3,872 $764,000
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $427,375 - $499,078
-2,761 Reduced 34.99%
5,129 $879,000
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $65,845 - $75,025
-412 Reduced 4.96%
7,890 $1.44 Million
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $1.14 Million - $1.29 Million
8,302 New
8,302 $1.29 Million
Q3 2020

Oct 29, 2020

SELL
$85.91 - $100.83 $322,076 - $378,011
-3,749 Closed
0 $0
Q2 2020

Aug 11, 2020

BUY
$73.37 - $98.18 $275,064 - $368,076
3,749 New
3,749 $368,000
Q1 2020

Apr 21, 2020

SELL
$64.5 - $97.79 $388,612 - $589,184
-6,025 Closed
0 $0
Q4 2019

Jan 17, 2020

SELL
$72.13 - $90.25 $305,542 - $382,299
-4,236 Reduced 41.28%
6,025 $533,000
Q3 2019

Nov 06, 2019

SELL
$62.98 - $75.72 $375,171 - $451,064
-5,957 Reduced 36.73%
10,261 $751,000
Q2 2019

Jul 17, 2019

SELL
$65.7 - $83.98 $18,921 - $24,186
-288 Reduced 1.74%
16,218 $1.19 Million
Q1 2019

Apr 17, 2019

BUY
$77.14 - $90.79 $1.02 Million - $1.2 Million
13,260 Added 408.5%
16,506 $1.33 Million
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $252,701 - $311,648
3,246 New
3,246 $251,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Harvest Investment Services, LLC Portfolio

Follow Harvest Investment Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Investment Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Investment Services, LLC with notifications on news.